Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo

PDF  |  How to cite

Oncotarget. 2017; 8:60724-60724. https://doi.org/10.18632/oncotarget.20600

Metrics: PDF 2703 views  |   ?  

Kowthar Y. Salim1,*, Saman Maleki Vareki2,*, Wayne R. Danter1, Serban San-Marina7 and James Koropatnick2,3,4,5,6

1 Critical Outcome Technologies Inc., London, Ontario, Canada
2 Cancer Research Laboratory Program, Lawson Health Research Institute, London, Ontario, Canada
3 Department of Microbiology and Immunology, Western University, London, Ontario, Canada
4 Department of Pathology, Western University, London, Ontario, Canada
5 Department of Oncology, Western University, London, Ontario, Canada
6 Department of Physiology and Pharmacology, Western University, London, Ontario, Canada
7 Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic School of Medicine, Rochester, Minnesota, USA
* These authors have contributed equally to this work

Published: September 01, 2017

This article has been corrected: Dr. Serban San-Maria was added to the author list. The authors sincerely apologize for this oversight

Original article: Oncotarget. 2016;7:41363-79. DOI:https://doi.org/10.18632/oncotarget.9133.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20600